Seeing is believing: Updates in retinal imaging  by Kozak, Igor & Williams, Linda
Editorial
Saudi Journal of Ophthalmology (2014) 28, 79–80Seeing is believing: Updates in retinal imagingo
f
s
w
t
w
a
a
h
a
w
s
r
o
s
a
i
n
h
c
n
i
i
b
a
a
i
w
f
t
m
f
i
a
t
n
w
i
c
C
w
fIt is truly not easy to imagine a subspecialty in ophthalmol-
gy that has so dramatically changed its appearance as the
ield of retina and retinal diseases. More than a decade ago
urgical retina was mostly large gauge and time consuming
hile medical retina used invasive diagnostics with limited
reatment options. As the advances in retinal therapeutics
ere on its way, the most dramatic changes were, in fact, cat-
pulted by innovations in non-invasive retinal imaging. The
dvent of optical coherence tomography in ocular imaging
as translated into an abundance of observations, knowledge
nd clinical applications.1–3 Optical coherence tomography
ith its incremental improvements over recent years has
haped the status and practice of both medical and surgical
etina to a level that no one would have easily predicted.
As once famous Henry D. Thoreau (1817–1862) pointed
ut ‘‘It’s not what you look at that matters, it’s what you
ee’’ may reflect how technology has transformed the retina
s we knew it into a different entity. Increased resolution that
maging devices allow us now not only shows what we could
ot see before but the whole concept of our understanding
ow the retina behaves in health and disease has started to
hange. New observations and knowledge constantly open
ew concepts and questions, and most importantly – the
nterest to pursue. The times between impactful innovations
n retinal imaging have been rapidly shortening, often times
eyond our ability to carefully register, process and adapt
ll or at least some of them.
Adaptive optics is another great example of an evolution-
ry step in retinal imaging. Although derived from astrophys-
cs, it is showing a potential to serve ophthalmology quite
ell. Once saturated with en-face and retinal B-scan profiles
rom new generation spectral-domain optical coherence
omography, the investigators and ophthalmologists have
oved to visualize arrays of individual retinal cells from a dif-
erent aspect. Critical analyses are ongoing with respect to
mage acquisition systems and recognition of photoreceptor
nd other cellular as well as microvascular morphology with
his application.4,5
As this would not be enough, we now can image retina’s
eighboring structures such as the choroid and the vitreous
ith detailed vitreoretinal interface.6,7 With new elucidations
n retinal pathophysiology we have learned that these adja-
ent structures have tremendous impact on the retina itself.
horoidal imaging is a new kid on the block who everybody
ants to see and know. Ophthalmic literature appears
looded with information on the choroidal status in differentPeer review under responsibility
of Saudi Ophthalmological Society,
King Saud Universitydisorders including inflammatory diseases and dystrophies.
Imaging of vitreoretinal interface, on the other end, is deci-
sive for either surgical or new medical interventions with
drugs such as ocriplasmin.8,9 Conditions such as vitreomacu-
lar adhesion and traction now truly attract our attention and
await our therapeutic decision based on follow-up imaging.
At times, however, we are still doubtful as to what actually
we are seeing with these new imaging devices and whether
we can believe what we see on the scans. Good examples
are analysis of the retinal outer hyper-reflective complex,
choroidal layers and sclerochoroidal junction, the extent of
true vascular non-perfusion on ultra-wide field fluorescein
angiography and images of photoreceptor mosaics pro-
duced by adaptive optics technology. Histologic correlations
in humans are not easy to obtain for natural reasons and for
the most part we instinctively believe that what we are seeing
is true.
This journal issue aims to update the reader on retinal and
choroidal imaging currently in use in ophthalmology practice.
It consists of review articles describing different imaging
techniques or diseases as well as worthy advances in retinal
therapeutics. It also presents clinical studies, cases and
observations where retinal and choroidal imaging has con-
tributed to diagnosis or new clinical observation(s). It con-
tains a review on artifacts in retinal imaging to alert
physicians what should not confuse our clinical judgment as
‘‘The art of being wise is the art of knowing what to over-
look’’ (William James 1842–1910). It is likely that the informa-
tion presented in this issue will soon become obsolete and
will be replaced by new innovations but until then let us
believe what we can see in retina today.
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